Unicycive Therapeutics, Inc.
Unicycive Therapeutics, Inc.
Your view on UNCY
Overview
What the company does, where it operates, and who runs it.
About Unicycive Therapeutics, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Shalabh K. Gupta MPA
- Headquarters
- 4300 El Camino Real, Los Altos, CA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Shalabh K. Gupta MPA
- Headquarters
- 4300 El Camino Real, Los Altos, CA, US
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.